Literature Scan

Literature Scan

New and noteworthy research from the medial literature landscape

Preexisting Cardiovascular Conditions Nearly Double Heart Failure Risk Among Non-Hodgkin Lymphoma Survivors

Patients with non-Hodgkin lymphoma (NHL) that was treated with anthracycline-based chemotherapy have an increased risk of heart failure (HF), and the chances are even...

Study Highlights Challenges in Treating Young Patients With Lymphoid Malignancies

In the EURO-LB02 trial, children and adolescents with lymphoma received the Non-Hodgkin Lymphoma-Berlin-Frankfurt-Münster (NHL-BFM90) protocol without prophylactic cranial radiotherapy, to determine whether replacing prednisone...

Comparing Quality of Life Between Inpatient and Outpatient Hematopoietic Cell Transplantation for Myeloma

Although previous research has shown that outpatient autologous hematopoietic cell transplantation (AHCT) is safe and feasible for patients with multiple myeloma (MM) – and...

Anti-CD19 CAR T-Cell Therapy Results in Sustained Molecular Remissions in Patients With Ibrutinib-Refractory CLL

Patients with chronic lymphocytic leukemia (CLL) with complex cytogenetics who relapse after treatment with ibrutinib have few treatment options and a short expected survival....

Older Patients With AML Have Suboptimal Use of End-of-Life Care

Many older patients with acute myeloid leukemia (AML) do not receive hospice care, and many of those who enroll do so only days before...

Bosutinib BFORE Imatinib: Evaluating Frontline Treatment for Patients With Newly Diagnosed CML

Results from the phase III BFORE trial suggest that treatment with the second-generation tyrosine kinase inhibitor bosutinib is associated with higher rates of cytogenetic...

Combination Antiplatelet Therapy Associated With Higher Mortality After ICH Than Single Antiplatelet Therapy

Antiplatelet therapy (APT) is associated with increased risk of intracerebral hemorrhage (ICH), though data about the association between APT use and mortality risk after...

Post-AHCT Maintenance Therapy With Rituximab Prolongs Survival in MCL

Maintenance therapy with the anti-CD20 monoclonal antibody rituximab after autologous hematopoietic cell transplantation (AHCT) prolonged event-free, progression-free, and overall survival in patients with mantle...

Treating Financial Toxicity: Subsidies Improve Access to Oral Therapies for Medicare Beneficiaries With Myeloma

Low-income subsidies (LIS), which are available to Medicare beneficiaries who earn less than 150 percent of the federal poverty level, alleviate the financial burden...

Real-World Analysis Confirms Rivaroxaban Reduces Risk of VTE and Major Bleeding, Compared With Warfarin

Previously, a series of phase III trials from EINSTEIN investigators determined that the direct oral anticoagulant (DOAC) rivaroxaban is non-inferior to enoxaparin and warfarin...
Advertisement

Current Issue

December 2017, Volume 3, Issue 14

This issue features physicians' insights on gun control, the use of cannabis for symptom relief, and more.